Manila Bulletin
Solons back plan to borrow more money, sell gov't properties for COVID 19 vaccine
President Rodrigo Duterte vowed to sell national assets and secure loans to ensure the procurement of COVID-19 vaccines for Filipinos.
Lawmakers have expressed full support for the President's plan to borrow more money and sell government properties for vaccine procurement.
Some lawmakers emphasized that funding for vaccine purchase should be of highest budget priority.
The Philippines would need approximately 110 million vaccine doses to cover the entire population.
Duterte anticipates that vaccines could be available towards the end of the year, with several countries like Russia, China, and the US in the final stages of development.
He referenced promising developments from US firm Moderna and the Oxford-AstraZeneca vaccine, both nearing their final trial stages.
Topics in this story
Explore more stories about these topics.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
President Rodrigo Duterte, in his fifth State of the Nation Address, urged Filipinos not to lose hope and announced that a COVID-19 vaccine is "just around the corner."
Read more →
Senator Christopher Lawrence "Bong" Go described President Rodrigo Duterte's fifth State of the Nation Address (SONA) as "inspiring."
Read more →
The Philippines is in communication with US pharmaceutical companies Pfizer, Johnson & Johnson, and Moderna to secure potential COVID-19 vaccines.
Read more →
President Rodrigo Duterte has committed to allocating funds for the purchase of high-flow nasal cannulas to assist COVID-19 patients experiencing oxygen deprivation.
Read more →
Vice President Leni Robredo emphasized that the Philippines must proactively combat the spread of COVID-19 rather than solely relying on the eventual arrival of foreign-developed vaccines.
Read more →